sk&f-38393 has been researched along with uric acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abraini, JH; Fechtali, T; Rostain, JC | 1 |
1 other study(ies) available for sk&f-38393 and uric acid
Article | Year |
---|---|
Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF 38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Apomorphine; Ascorbic Acid; Cerebral Ventricles; Corpus Striatum; Dopamine; Dopamine Agents; Electroencephalography; Ergolines; Homovanillic Acid; Injections, Intraventricular; Kinetics; Male; Methyltyrosines; Pargyline; Pressure; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Synapses; Uric Acid | 1992 |